Article thumbnail

Anti-inflammatory effects of pre-seasonal Th1-adjuvant vaccine to Parietaria judaica in asthmatics

By Nicola Scichilone, Chiara Minaldi, Roberta Santagata, Salvatore Battaglia, Gaetana Camarda and Vincenzo Bellia
Topics: Original Research
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:3108305
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2001). A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines. Int Arch Allergy Immunol.
  2. A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections.
  3. Allergic rhinitis and its impact on asthma update: allergen immunotherapy.
  4. Allergoid-specific T-cell reaction as a measure of the immunological response to specific immunotherapy (SIT) with a Th1-adjuvanted allergy vaccine.
  5. Assessment of exhaled breath condensate pH in exacerbations of asthma and COPD: a longitudinal study.
  6. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations.
  7. Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in children.
  8. EIA and GC/MS analysis of 8-isoprostane in EBC of children with problematic asthma.
  9. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med.
  10. Exhaled breath condensate: methodological recommendations and unresolved questions.
  11. (2008). Global Initiative for Asthma. GINA report. Global strategy for asthma management and prevention.
  12. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children.
  13. Immunotherapy with cat- and dog-dander extracts. V . Effects of 3 years of treatment.
  14. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients.
  15. Increased exhaled 8-isoprostane in childhood asthma.
  16. Interpretative strategies for lung function tests.
  17. Isoprostanes: an overview and putative roles in pulmonary pathophysiology.
  18. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma.
  19. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids.
  20. placebocontrolled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol.
  21. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).
  22. Pollinex Quattro Tree: allergy vaccine.
  23. (2001). Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy.
  24. (2003). Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A. Infect Immun.
  25. Safety evaluation of a glutaraldehyde modified tyrosine adsorbed housedust mite extract containing monophosphoryl lipid A (MPL) adjuvant: a new allergy vaccine for dust mite allergy.
  26. (2001). Standardisation of glutaraldehyde-modified tyrosine-adsorbed tree pollen vaccines containing the Th1-inducing adjuvant, monophosphoryl lipid A (MPL). Allergol Immunopathol (Madr).
  27. The effect of specific immunotherapy on exhaled breath condensate nitrite levels.
  28. (2003). The isoprostanes: unique products of arachidonic acid oxidation-a review. Curr Med Chem.
  29. The relationship between oxidative stress and acid stress in adult patients with mild asthma.
  30. (2010). Ultra-short course immunotherapy in children and adolescents during a 3-years post-marketing surveillance study. Pediatr Allergy Immunol.
  31. Ultra-short-course seasonal allergy vaccine (Pollinex Quattro).